Charlotte Pamer-Wieser
Corporate SecretaryNovartis
PharmaceuticalsView Profile →Company Secretary · AstraZeneca
Matthew Bowden is AstraZeneca’s company secretary. He previously served as deputy company secretary and became secretary of AstraZeneca PLC in May 2025.
Last reviewed: Nov 16, 2026
Matthew Bowden is AstraZeneca’s company secretary. He previously served as deputy company secretary and became secretary of AstraZeneca PLC in May 2025.
Bowden worked as deputy company secretary at AstraZeneca before taking the group company-secretary office. In February 2020, he also served as a director of MedImmune Limited, a group subsidiary.
He became secretary of AstraZeneca PLC on May 1, 2025. The same day, he also became secretary of AstraZeneca UK Limited, the operating subsidiary where he had held his earlier deputy-secretary position.
His company-secretary work includes regulatory notifications concerning AstraZeneca securities. On November 2, 2026, he signed its notification covering the admission to London trading of shares issued under employee share schemes during October.
No institution-specific degree entry is listed.